SLC2A1 rs80359821: What Your Genotype Means
The genetic variant rs80359821 is an extremely rare missense alteration situated within the SLC2A1 gene, which encodes the critical glucose transporter protein GLUT1. Alterations at this position compromise glucose delivery across the blood-brain barrier and are associated with exercise-induced paroxysmal dyskinesia and metabolic impairment during exertion. Because functional GLUT1 transport is essential for cerebral energy supply, variants in this gene are classified under the spectrum of GLUT1 deficiency disorders.
What each genotype means
Typical glucose transport
You carry two copies of the common reference allele for the SLC2A1 gene. Research associates this genotype with normal function of the GLUT1 transporter and typical cellular glucose uptake during physical exertion. You do not have the rare variant linked to exercise-induced paroxysmal dyskinesia.
Found in greater than 99.9% of individuals across all major ancestry populations worldwide.
Increased dyskinesia risk
You carry one copy of the rare missense variant in the SLC2A1 gene (c.667C>T, p.Arg223Trp). In clinical literature, heterozygous alterations at this site are associated with impaired GLUT1 transporter activity, which can manifest as exercise-induced paroxysmal movement issues or related metabolic strain. However, evidence is limited and symptoms can vary widely among individuals.
Extremely rare; observed in fewer than 1 in 10,000 individuals globally in gnomAD.
Severe metabolic impairment
You carry two copies of the rare missense allele in SLC2A1. Biallelic alterations in GLUT1 typically lead to severe impairment of glucose transport across the blood-brain barrier and prominent neurometabolic symptoms. This homozygous genotype is exceedingly rare in published clinical and population genetics records.
Extremely rare to vanishingly uncommon, with virtually no documented homozygotes in large reference population databases.
What Is rs80359821 and Where Is It Located?
The single nucleotide polymorphism rs80359821 represents a rare DNA sequence change located in the SLC2A1 gene on human chromosome 1. The SLC2A1 gene provides the blueprint for glucose transporter type 1, widely known as GLUT1. At this specific genetic position, a nucleotide substitution alters the amino acid sequence of the transporter protein, changing a key structural residue within the transmembrane transport channel. This missense mutation impairs the channel's capacity to facilitate the passive movement of D-glucose across cellular membranes. In clinical genetic databases such as ClinVar and dbSNP, alterations at this locus are documented in connection with glucose transporter-related movement disorders. Because the mutation disrupts a fundamental cellular carrier, it acts predominantly in a monogenic, dominant fashion rather than functioning as a subtle, common quantitative trait locus.
The Biological Role of the SLC2A1 Gene and GLUT1
The SLC2A1 gene is responsible for producing the primary vehicle by which the central nervous system receives its metabolic fuel. The human brain consumes roughly twenty percent of the body's baseline energy budget, relying almost exclusively on glucose for energy metabolism. Because glucose is a polar molecule, it cannot passively diffuse through the lipid-rich endothelial membranes that form the blood-brain barrier. The GLUT1 transporter sits densely packed in these blood-brain barrier endothelial cells and surrounding glial astrocytes, shuttling glucose out of the bloodstream and directly into brain tissue. When SLC2A1 carries a loss-of-function or missense defect, the overall rate of hexose transport into the cerebrospinal fluid and parenchyma drops markedly. This reduction creates an energetic deficit, termed hypoglycorrhachia, which leaves neurons vulnerable to metabolic exhaustion when physiological demand spikes.
Research Associations: Paroxysmal Dyskinesia and Physical Exertion
Mutations in SLC2A1, including rs80359821, are linked in clinical literature to paroxysmal exercise-induced dyskinesia (PED), sometimes classified alongside dystonia 18. PED is characterized by recurrent episodes of involuntary twisting, choreoathetosis, or muscle stiffening that are provoked specifically by sustained physical exertion, prolonged fasting, or psychological stress. During exercise, the brain's metabolic demand increases while peripheral muscles consume circulating glucose, intensifying cerebral energy starvation in individuals with defective GLUT1 transport. While classic GLUT1 deficiency syndrome often manifests in infancy with severe developmental delay and refractory epilepsy, missense mutations frequently produce milder, non-epileptic paroxysmal phenotypes that primarily emerge during physical exertion. Evidence strength for this specific variant remains classified as limited due to the small number of documented individual pedigrees, though the broader pathophysiological link between SLC2A1 disruption and exercise-induced dyskinesia is well established.
Population Frequency and Ancestry Patterns
According to large-scale population genomic resources such as the Genome Aggregation Database (gnomAD), the alternate allele responsible for rs80359821 is exceptionally rare. Across global cohorts, the minor allele frequency is estimated to be well below 0.001 (less than 0.1 percent), and it is entirely absent in most broad, unselected reference populations. Because pathogenic variants in the SLC2A1 transporter domain are subjected to intense negative selective pressure, they do not circulate at the elevated frequencies observed with common human traits. Many occurrences of SLC2A1-related disorders arise from de novo mutations—spontaneous events occurring in the germline—though once present, they can be transmitted down family lineages in an autosomal dominant inheritance pattern. There is currently no evidence indicating that this specific variant is enriched in any particular ancestral or geographical group.
Interpreting Your Results: Scope and Limitations
Discovering an annotated variant like rs80359821 on a genetic report requires cautious, context-aware interpretation. Direct-to-consumer genotyping arrays often exhibit elevated false-positive rates when probing exceedingly rare alleles, meaning that an unexpected finding in raw data must be independently validated through clinical-grade Sanger or next-generation sequencing before any conclusions are drawn. Furthermore, genetic markers describe statistical correlations and biological mechanisms; they do not constitute a standalone medical diagnosis. A true carrier of a pathogenic SLC2A1 variant might exhibit mild, intermittent symptoms or more pronounced movement patterns, as penetrance and expressivity can vary significantly even within the same family. Consumers should never attempt to alter their diet, exercise regimens, or medical care independently based on raw genomic data, but rather review findings with a certified genetic counselor or neurologist.
How common is this variant?
The rs80359821 variant is an exceptionally rare pathogenic variant present at an allele frequency of less than 0.001 across all major continental populations in gnomAD. Almost all individuals worldwide carry the homozygous common reference genotype.
Frequently asked questions
What is exercise-induced paroxysmal dyskinesia?
Exercise-induced paroxysmal dyskinesia is a neurological condition where sustained physical exertion, such as walking or running, triggers sudden and temporary involuntary movements. These episodes often present as muscle spasms, stiffness, or twisting movements, usually resolving after a period of rest.
How does SLC2A1 affect how the brain uses energy?
The SLC2A1 gene provides the code for the GLUT1 protein, which transports glucose across the blood-brain barrier into brain cells. If this transporter is impaired, the brain experiences a relative shortage of glucose, causing neurological symptoms when energy demand rises.
Can commercial consumer DNA tests reliably detect rs80359821?
Consumer genotyping platforms are designed primarily for common variants and have a higher rate of false-positive readings when testing for very rare mutations like rs80359821. Any unexpected finding from a direct-to-consumer test should be confirmed by a clinical-grade sequencing assay before making healthcare decisions.
Does having this variant guarantee someone will develop movement problems?
Not necessarily. While pathogenic SLC2A1 mutations have high clinical relevance, their expression and severity can vary widely among individuals, ranging from classic early-childhood symptoms to subtle exercise fatigue or mild paroxysmal symptoms later in life.
What should I do if my raw genetic data shows a variant in SLC2A1?
If your raw genomic data indicates an alteration in SLC2A1, you should share the report with a medical professional, such as a genetic counselor or neurologist. They can arrange confirmatory testing and evaluate your personal and family medical history in an appropriate clinical context.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs80359821?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29